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Abstract                   
The purpose of this literature review is to investigate what genetically engineered animals are 
being used for and if genome editing is going to be a useful tool in future animal breeding. 
Genetically engineered animals have been used within the biomedical research field since the 
seventies. The techniques of how to manipulate the genome of an organism has been 
developed from incorporations of transgenes via direct cytoplasmic microinjection into one-
cell-stage embryos, to techniques that can change specific bases in the genome without 
adding transgenes. The most recent technology are referred to as genome editing and it uses 
engineered nucleases to target and change the bases of interest. This new method for the 
introduction of mutations is thought to revolutionize the field of livestock production. A few 
examples of genetically engineered animals are brought up in this review. Improvements 
made in the animals have been better food utilization, disease resistant traits or more 
environmentally friendly farm animals. However, the biggest advantage of using genetically 
engineered animals in livestock production lies within the biomedical research field, and it is 
believed to do so in the future as well. 
 
Sammanfattning 
Syftet med denna litteraturstudie var att studera vad genetiskt modifierade djur används till, 
hur de produceras och om den nya tekniken som kallas genome editing kan komma att vara 
ett användbart verktyg i framtida avelsprogram för att öka eller gynna animalieproduktionen. 
Genetiskt manipulerade djur har använts inom medicinsk forskning sedan sjuttiotalet. 
Genmodifieringsteknikerna har utvecklats från att inkorporera transgener via mikroinjektion 
direkt i embryos, som befinner sig i en-cell-stadiet, till tekniker som effektivt kan ändra 
specifika baser på genomet utan att addera transgener. De senaste teknikerna kallas för 
genome editing och de bygger på att specifika nukleaser lokaliserar och ändrar baser på 
genomet. Denna nya metod som används för att introducera förbättrande mutationer tros 
revolutionera animalieproduktionen. I den här review artikeln finns några exempel på 
genetiskt förändrade djur. Egenskaperna som förbättrats är bättre foderomvandlingsförmåga, 
bättre resistens mot sjukdomar eller miljöförbättrande egenskaper hos lantbruksdjur. Den 
största fördelen med att kunna använda genetiskt förändrade djur är inom medicinsk 




Scientists have since the seventies been able to manipulate the DNA of living organisms using 
biotechnology. The discovery of embryonic stem cells (ESC) and its ability to colonize the 
germline was first found in mice and ESC-mediated transgenesis became a useful tool for 
gene targeting in 1981 (Polejaeva et al., 2015). The technique used to produce a transgenic 
animal back then was pronuclear microinjection (MI) of exogenous DNA directly into one-
cell-stage embryos (Gordon et al., 1980). The first genetically engineered farm animal was 
produced over 30 years ago by using this technique (Hammer et al., 1985). Successful 
somatic cell nuclear transfer (SCNT) using an embryo-derived differentiated cell population 
resulted in the breakthrough for genetically engineered animals, Dolly the cloned sheep in 
1996 (Campbell et al., 1996). SCNT has since then been used to produce cloned cattle, goats 
and pigs (Laible et al., 2015; Polejaeva et al., 2015; Tan et al., 2016). 
 
Techniques have been further developed and new methods have been suggested, one of which 
is genome editing. Genome editing is based on engineered nucleases that can locate a specific 
target site at the genome. The nucleases induce a double stranded break (DSB) that are 
followed by one of the two repair mechanisms, the error prone non homologous end joining 
(NHEJ) or homology directed repair (HDR) (Gaj et al., 2013). Edits of the genome is 
achieved in the repair process. HDR can introduce one or several transgenes if an engineered 
nuclease, together with a donor plasmid, bearing locus-specific arms, is co-delivered into an 
endogenous locus. To provoke mutations, insertions or deletions, single stranded DNA 
oligonucleotides and a linear donor sequences with <50 bp of homology can be used instead. 
The NHEJ mediated repair pathway after a DSB causes small insertions or deletions that 
results in knockout (KO) of gene function because of a frameshift mutation. (reviewed in Gaj 
et al., 2013). 
 
The engineered nucleases or designer nucleases, as they are also called, can be divided into 
two classes. The first one includes the zink finger nuclease (ZFN) and the transcription 
activator like effector nuclease (TALEN), both are modular protein containing a specific 
DNA binding domain and a catalytic cleavage domain consisting of the restriction enzyme 
fokI. The second group includes the meganucleases and the clustered regulatory interspaced 
palindromic repeat/CRISPR associated gene (CRISPR/Cas) system. The CRISPR/Cas system 
is increasing rapidly in livestock genetic research. (Reviewed in Sander & Joung, 2014; Jenko 
et al., 2015; Tan et al., 2016). 
 
The first genome edited animal depended on modification of primary cells which were later 
used as nuclear donors for embryo reconstruction in SCNT (Hauschild et al., 2011). This was 
followed by direct modification of the zygote through cytoplasmic injection (CPI) (Tan et al., 
2016). In the past five years more than 300 pigs, cattle, sheep and goats have been genome 
edited. The genome edited animals can potentially serve as organ donors, disease models, 
bioreactors or new lines of high producing or disease resistant farm animals. (Carroll & 
Charo, 2015; Tan et al., 2016). The biggest advantage of producing genetically engineered 
animals lies within the biomedical field, but also within the farm animal industry (Laible et 
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al., 2015). So far only one transgenic animal is available for food consumption 
(AquaAdvantage® salmon) (Commissioner, 2016), even though many attempts have been 
made, for example to breed more environmentally friendly animals for meat production 
(Enviropig®) (Golovan et al., 2001). This might change now as genome editing allows 
specific changes in the genome without leaving any traces of transgenes (foreign DNA) in the 
produced animal (Tan et al., 2016).  
 
The purpose of this literature review is to investigate what genetically engineered animals are 
being used for and if genome editing is going to be a useful tool in future animal breeding in 
the prevention of an upcoming food crisis in the world.  
 
One of the promising techniques within the field of genome editing  
The CRISPR-Cas system was found in bacteria and archaea and enables to detect and protect 
against mobile genetic elements. The system matches DNA-sequences from virus or plasmids 
and is believed to help the adaptive immune system to fight foreign genetic material. Genetic 
and biochemical experiments confirmed this hypothesis. (Jinek et al., 2012). The CRISPR-
Cas type II system uses an endonuclease, with the name Cas9 (Charpentier & Doudna, 2013). 
This enzyme can, together with a guide RNA, locate and splice foreign DNA at specific 
locations demarcated of conserved sequences called proto-spacer adjacent motifs (PAMs). To 
form the functional DNA-target complex, Cas9 needs two distinct RNA transcripts, CRISPR 
RNA (crRNA) and trance-acting CRISPR RNA (tracrRNA). The double RNA can configure 
into a single-guide RNA (sgRNA) that include a sequence which is adequate to program Cas9 
to create a DSB in target DNA. (Jinek et al., 2012; Charpentier & Doudna, 2013). The DSB is 
thereafter repaired by one of two repair pathways, NHEJ or HDR (Gaj et al., 2013). Studies 
where Cas9 coding mRNA, together with a guide RNA, was injected into one-cell-stage 
embryos of zebrafish produced high frequencies (24-25%) of insertions and deletions 
(specific kinds of mutations) (Hwang et al., 2013). This was interpreted as an indicator that 
the method can work in mammals and plants as well (Hwang et al., 2013). Using the Cas9 
enzyme has enabled modification of endogenous genes in organisms that before have been 
difficult to manipulate genetically (Sander & Joung, 2014).  
 
Genetically engineered (GE) animals 
Examples of recently produced farm animals created with the latest techniques 
The basic method of how to produce a genome edited sheep using the CRISPR/Cas system 
together with CPI were described in Crispo et al., (2015a). The ovaries from newly 
slaughtered sheep were recovered from the slaughterhouse and transported to the laboratory 
where the cumulus oocytes complexes were aspirated in recovery medium. The bulbous 
oocytes were fertilized with frozen-thawed semen. Cas9 mRNA and sgRNA were thereafter 
microinjected into the cytoplasm to induce a spontaneous mutation at a specific site. The aim 
of a specific case described in the study was to knock out the myostatin (MSTN) gene, which 
is a negative regulator of muscle growth. The zygotes were, after a couple of days of 
maturation in vitro, transferred into surrogate ewes that were synchronized to be on the same 
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day in the estrous cycle as the zygotes. Out of 53 grade one (successful developed) blastocysts 
inserted in 29 recipient ewes 22 lambs were born. Three of those died at delivery or within the 
first day after birth. Biopsies followed by PCR showed that nine live lambs and one of the 
dead lambs carried the desired mutation, among the living lambs carried eight a homozygous 
and two lambs a heterozygous version. The lambs with the homozygous mutation in the 
MSTN gene showed 60 days postpartum a significant difference in measured weight 
compared to the wild type lambs, the lambs carrying the mutation at both alleles were 20 to 
30 % heavier than other lambs. (Crispo et al., 2015a). 
 
Liu et al., 2014 produced genetically engineered cows that expressed human lysozome 
(hLYZ) in the milk. Lysozome is an antimicrobial protein that plays an important role in the 
defense against bacterial infections, and human lysosome has better antimicrobial properties 
than bovine lysosome (Liu et al., 2014). The somatic cells used in the study were manipulated 
with ZFN together with SCNT, and out of 118 embryos inserted into recipient cows, five 
calves were born alive. The milk of the genome edited cows showed no significant difference 
in milk composition, when comparing fat, protein and lactose content with normal cows. 
However, when bacterial infection was induced by intra mammary infusion of S. aureus, E. 
coli or S. agalactiae in the mammary gland, 19 out of 20 glands in non-transgenic cows 
received infection but none of the genome edited cows did (Liu et al., 2014). Scientists of the 
same group also produced cows expressing lysostaphin in the milk with the same method and 
the same purpose as for the hLYS cows. It is stated in the article that 5799 embryos were 
successfully reconstructed, 140 pregnancies were observed and 8 out of 14 borne calves were 
still alive one month after birth (Liu et al., 2013).  
 
Yu et al., 2011 produced genome edited cows that didn’t express beta-lactoglobulin (BLG) in 
the milk. BLG is a whey protein that causes milk protein allergies. The gene was knocked-out 
using the ZFN technique together with SCNT. Out of 995 reconstructed embryos 50 
developed into pregnancies, and eight genome edited calves were born, but six of the calves 
died soon after birth (Yu et al., 2011). 
 
Luo et al., 2014 manipulated Chinese yellow cattle to achieve a knockout mutation of the 
MSTN gene using ZFN-mediated mutagenesis together with SCNT. Mutation of the MSTN 
gene occurs naturally in Belgian Blue and Piedmontese cattle at high frequencies and it 
increases the muscle mass in these breed by an average of 20 % (Ansay & Hanset, 1979; 
Kambadur et al., 1997). In total 1336 embryos were reconstructed, some of them were 
inserted in cows, and it resulted in 35 pregnancies, and out of 18 born calves two calves did 
carry the mutated gene (Luo et al., 2014). 
 
Manipulation of several genes simultaneously was done by Ni et al., (2014), using the 
CRISPR/Cas9 method, who showed that it was possible to achieve mutations in four genes at 
the same time (MSTN, Prp, BLG and NUP). However, only the experiment with fibroblasts 
carrying mutation in the MSTN gene was used for SCNT and it resulted in the birth of two 




Zygotes from bigger mammals (pigs) were subject to manipulation with CPI for the first time 
in 2013 at the Roslin Institute in Edinburgh. In total 367 zygotes were injected with different 
concentration of RELA TALEN mRNA. The RELA gene was edited to cause resistance to 
the African swine fever, a viral infection that affects domestic pigs. After three days in vitro, 
21 % of the embryos screened positive for edits in the RELA locus, and five live piglets were 
born which carried the porcine RELA mutation (Lillico et al., 2013). 
 
Whitworth et al., (2014) tested if the CRISPR/Cas technique was as effective to produce 
edited pigs with CPI as with SCNT. They manipulated two genes, CD163 and CD1D, which 
are involved in porcine virus infections. A total of 2734 embryos with presumptive CD163 
edit were produced with SCNT, and 34 edited piglets were born alive. Additionally 1055 
embryos with presumptive CD1D edit were produced with SCNT, and 12 gene-edited piglets 
were born. A total of 96 embryos with presumptive CD163 edit produced with CPI, resulted 
in four live edited piglets. And finally, 110 embryos with presumptive CD1D produced with 
CPI, resulted in four live edited piglets (Whitworth et al., 2014). 
 
In 2015 the first genome edited sheep and cattle were produced using CPI together with 
TALEN mRNA, targeting a knockout of the MSTN gene. A total of 20 edited bovine 
embryos were transferred into 11 recipient cows, and it resulted in two full term twin 
pregnancies. However, only one of the pregnancies resulted in the birth of two calves, one 
heifer and one bull, and only the bull carried the mutation (Proudfoot et al., 2015). The same 
experiment was done in sheep. From a total of 26 blastocysts transferred into nine recipient 
ewes 12 live lambs were born from eight successful pregnancies, although only one lamb 
carried the mutation (Proudfoot et al., 2015). 
 
The polled (hornless) trait is a desired trait in farmed cattle breed. Horned cattle can injure 
other animals in the herds or people working with the animals. Dehorning of cattle is 
associated with pain and stress for the animal and is also a costly procedure. The polled allele 
is naturally occurring in some cattle breed, for example the Angus. The trait can be introduced 
into horned cattle breeds by normal crossbreeding but unwanted effect like lower milk yield 
for example often follows as well. Tan et al., (2013) successfully introduced the polled allele 
into the genome of Holstein, a cattle breed that naturally inherits horn. The allele was 
introduces by a plasmid HDR template containing fragments from the Angus breed polled 
allele. Out of 226 colonies five screened positive for the introgression of the new allele. (Tan 
et al., 2013).  
 
A simulation study by Jenko et al., (2015) proposed a method of how to promote favorable 
alleles by genome editing. Animal breeding aims to increase the genetic merit of traits that are 
valuable in the production. These traits are often controlled by several quantitative traits 
nucleotide (QTN). Recent use of genomic selection (GS) associate phenotype with markers at 
the genome. This method speed up genetic gain, but with conventional breeding the 
frequencies of favorable alleles at the QTN will still be slow to achieve because of the low 
level of recombination during meiosis. Implementation of genome editing in breeding 
programs would allow individual alleles at QTN to be removed or added and this will rapidly 
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increase the genetic merit for valuable traits in livestock breeding. Ten simulations scenarios 
was performed where 25 sires was selected on the basis of their true breeding value (TBV) 
and then they were edited for various amounts of QTN (0-100), with the assumption of 
entirely additive QTN. A number of 1000 candidates were generated in each generation and 
20 generations were counted for. The changes in frequencies of favorable alleles using only 
GS were 0.02 and 0.04 using GS combined with genome edited sires. The best results for 
cumulative response was when top five TBV sires were edited in 100 QTN, it resulted in a 
4.12 times greater cumulative response than with only GS. (Jenko et al., 2015). 
 
 
GE animals for commercial use 
AquaAdvantage® salmon 
The AquaAdvantage® salmon was first produced in 1989. It was produced by microinjecting a 
growth hormone (GH) transgene into the cytoplasm of a fertilized, non-water activated 
salmon eggs (Cook et al., 2000). In September 1995 the company Aquabounty technologies 
applied for an investigation for future approval by the U.S. Food and Drug Administration 
(FDA) of their transgenic salmon (reviewed in Van Eenennaam & Muir, 2011). The new gene 
incorporated in the salmon that enhances growth is classified as a drug by the FDA, therefore 
it needs to undergo certain risk assessment. The salmon was finally approved to be safe to eat 
and to be sold for human consumption, in USA, in November 2015. The only production 
environment approved is land-based contained hatchery tanks, which are located in Canada 
and Panama. This aims to eliminate the risk of any salmon escaping into seawaters. As an 
additional precaution the fish are made reproductively sterile and are unable to breed in the 
wild. (Commissioner, 2016). The aqua advantage salmon contains rDNA that originates from 
the Chinook salmon, and the expression of this gene is under the control of an antifreeze 
protein promotor from an Ocean Put. The promotor turns the gene expression on and allows 
the GE salmon to grow faster (Medicine, 2016; Cook et al., 2000; Van Eenennaam & Muir, 
2011). A study by Cook et al., (2000) showed that the aqua advantage salmon had a 10 % 
better food utilization than the non-transgenic salmon and it reached the weight of 55 g four 
months earlier. According to the information on the website of Aquabounty, the transgenic 
salmon reaches a size of 4 kilo more than 200 days before the non-transgenic salmon (600 
days vs 850 days) (Technology, 2016). 
 
Enviropig® 
The enviropig® was a transgenic pig firstly produced in 1999. The pigs were produced for the 
purpose of reducing phosphorus (P) leakage from the manure - with the aim to produce a 
more environmentally friendly farm animal. Pronuclear microinjection of the PSP/APPA 
transgene (parotid secretary protein promoter linked to the e-coli appA phytase gene) into 
embryos resulted in pigs which expressed phytase in their salivary gland and were able to 
digest phytate. The transgenic pig reduced the excreted phosphorus by up to 75 % (Golovan et 
al., 2001). A study by Novoselova et al., (2013) evaluated the economic gain for farmers 
keeping the GE pig, regarding the effect of the Enviropig®. They could show that the costs of 
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a piglet produced were 2.5 % less than the non-enviropig, under the presumption of a stable 
meat price. The main reason for the cost reduction was that less P was required in the feed 
and manure cost was reduced due to fewer minerals in the manure (Novoselova et al., 2013). 
Despite the good results, the funding’s for the enviropig project reached an end in 2012 and 
all the remaining pigs had to be euthanized (Clark, 2015). 
 
Glofish® 
Not surprisingly, the Glofish® derive from zebrafish as the zebrafish is one of the most widely 
studied species within biological research. A protein expressing fluorescent color extracted 
from jellyfish or sea coral, was incorporated into the zebrafish to study cellular processes. 
Since the luminous color attracts the human eye, someone sought to sell them as pet fish. The 
Glofish® can now be purchased and kept in home aquarium in the US but they are banned 
elsewhere. The first glofish was first produced in Singapore 1999. (Davies, 2014). 
 
Animals in biomedical research 
It has been hypothesized that the latest techniques for manipulating the genome (genome 
editing) in farm animals increases the availability of livestock models for biomedical 
research. Mouse models have a long history as a model species within the research industry. 
In the past 25 years the mouse has contributed to the understanding of gene functions and 
regulations. The mouse is most often the first animal used for trials for clinical experiments. 
However, translating clinical trials from mice to humans has a low level of success rate. This 
is most likely due to the small body size and short lifespan of mice. Bigger animals such as 
cows, pigs, goats and sheep can replace their role in research and serve as better models for 
humans, especially when techniques for genome manipulations with higher success rates are 
developed (Polejaeva et al., 2015).  
 
Cattle (Bos taurus)  
Cattle are an excellent model for human female reproduction and ovarian function as they 
have a similar reproduction cycle to women. Assisted reproductive technologies (ART) are 
used in humans and cattle. A higher risk of abortion and pregnancy problems due to abnormal 
placentation is associated with ART in women as well as cows (Polejaeva et al., 2015). 
 
Sheep (ovis aries)  
Sheep are useful for studying the respiratory organs. Size of the lungs and breathing 
frequency is much like humans. A lot of research is being done for asthma and cystic fibrosis 
(Tebbutt et al., 1995). Sheep are also commonly used as a model for pharmacological testing 
as certain brain structures are similar to that of human (Jacobsen et al., 2010). 
 
Goats (capris hircus)  
Goats are used for research on atrial fibrillation, the most common serious abnormal heart 
rhythm. A trans-genetic goat that overexpresses the growth factor TGF-Beta1 has been breed 
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to be used as a model for atrial fibrillation. Goats are also used for investigations of 
mechanical circulatory support and a model for complete female-to-male XX sex reversal as a 
result of genomic mutation (Pannetier et al., 2012; Polejaeva et al., 2015). 
 
Pigs (Sus scrofa)  
Pigs are commonly used in biomedical research. They reach sexual maturity early in life, they 
breed all year around and they have large litter size, these traits make them into excellent 
research models. Many transgenic pigs have been produced to serve as models for human 
disorders and diseases (Polejaeva et al., 2015). One core idea of the use of pigs is the idea of 
xenotransplanation, thus changing the animals to reduce organ rejection in human after 
transplantation (Dooldeniya & Warrens, 2003). 
 
Discussion  
In order to feed the growing population in the world new technology should be explored to 
increase the food production. Genetic modification of plants and farm animals is one possible 
way to achieve this (Crispo et al., 2015b; Laible et al., 2015). Incorporating genome editing in 
existing breeding program can speed up genetic gain that otherwise would take several 
generations. It would also reduce expenses both primarily and secondary. Primarily because 
less animals are needed for selection and secondary because achievable traits can add 
economic gain for the farmer (Novoselova et al., 2013; Carroll & Charo, 2015; Jenko et al., 
2015).  
 
Many GE animals have already been produced within the biomedical field but so far only one 
is available on the market for food consumption. The technique of genetically manipulating 
an organism was first applied to animals, but the technique has since been much more widely 
used within the plant and crop industry. There are a number of transgenic plants and crops out 
on the market in several different countries (Laible et al., 2015). Transgenic plants seems to 
be easier for people to accept as a food source, additionally plants are easier to produce. The 
long reproduction cycles of animals and animal welfare concerns are obstacles to overcome in 
making GE animals a general success (Laible et al., 2015). In the listed examples of recently 
produced GE animals, the success rate of getting live animals appears to be very low, yet, the 
authors of the reports put forward the technique as being a revolutionary technique, ready to 
be applied in animal breeding (Crispo et al., 2015a; Liu et al., 2013; Yu et al., 2011; 
Whitworth et al., 2014; Proudfoot et al., 2015; Jenko et al., 2015). Many of the difficulties are 
due to the fact that SCNT is a very difficult technique to master and the low percentage of 
successes (live born animals), is partly due to the massive amount of cloned somatic cells that 
are being cultivated but never used. The scientists safeguard themselves to get some progeny 
of the clones, or to be able to pick the most viable clones for transferring them into surrogates. 
Calculating the success rate (percentage of animals born alive) from the amount of inserted 
embryos is a better alternative to get accurate results. SCNT is highly associated with 
abortions and defects at birth, as well as early post-natal death. This adds to the relatively low 
live born rate and early death in the examples shown here. However, SCNT is a well-
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established technique for cloning farm animals and so far 33 out of 43 successful genome 
edited animals has been done using SCNT (Tan et al., 2016). On average, out of 130 
reconstructed pig embryos transferred with SCNT, only one piglet is being born. To deal with 
the problems associated with SCNT, another technique, CPI, is starting to be more widely 
used. The technique of CPI is thought to be easier to manage than SCNT, but the success rate 
of getting live born animals is still low (pig 37% vs 76% for SCNT). However, CPI only 
requires an average of 24 pig embryos to achieve one live piglet (Tan et al., 2016). The main 
aspect of using SCNT is that the newly introduced mutation can be detected before insertion 
in recipient surrogates and possible saving the labor of transferring supposedly edited 
embryos, in contrast to CPI where the edited animal cannot be identified until the birth.  The 
positive effect of using CPI is that the zygotes that are being used, includes genomes from 
two parental gametes and thus the genetic variation is being preserved. Manipulation 
techniques using CPI is thought to be the favorable method to produce genome edited farm 
animals in the future (Ni et al., 2014; Tan et al., 2016).  
 
What can the GE animals be used for 
Bovine expressing hLYZ or lysostaphin in their mammary gland would be resistant to gram-
positive bacteria like S. aureus. Having such genome edited cows in a dairy herd would be a 
big advantage since mastitis caused by S. aureus requires the use of antibiotic, which in turn 
will increase costs for the farmer (Liu et al., 2014). The genome edited bovine will also have 
a general negative effect of antibiotic use. Another big advantage with transgenic dairy cows, 
would be the opportunity to manipulate the genome so that they produce milk that is more 
similar to human milk. The milk would be an excellent infant formula or would allow people 
with allergies to normal milk to consume milk. Concerning meat, the traits of interest often 
lies within producing more meat at a lower cost. This requires the breeding of animals with 
better food utilizations traits. One way of achieving this is by causing a mutation in the 
MSTN gene. The MSTN gene is well recognized and easy to target for scientists. Another 
way to achieve increased growth is to insert a transgene including a growth factor hormone, 
like in the example with the salmon. But maybe more interesting would be to produce farm 
animals with healthier meat, containing more essential fatty acids (omega 3) (Laible et al., 
2015). The examples of application of GE for the production of healthier and more disease 
resistant herds are possibly the areas which would be most accepted by the general public. 
Lethal mutations could be eliminated or treated with GE. Lillico et al., (2013) produced 
genome edited pigs, with edits in the porcine RELA gene, with the aim to produce pigs 
resistance to the African swine fever. The viral infection affects domestic pigs but African 
pigs such as warthogs appear to be resistant to the virus. Producing animals that are more 
environmentally friendly, is another important topic and a major concern for future food 
production. The Enviropig® that reduced its P output with up to 75 % could have been a huge 
success (Golovan et al., 2001). Breeding or producing transgenic animals that are serving a 
purpose of a pet (Glofish®) might, however, not make much sense. 
 
When applying the most recent developed techniques of genome editing summarized in this 
review (ZNF, TALEN and CRISPR) it is possible to manipulate specific bases of single genes 
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in the genome of farm animals with high precision. However, the legislation has yet to decide 
on the classification of these techniques. The genome edited animals would under most of the 
current legislation, likely not be classified as transgenic animals. The edits made would rather 
been seen as normal mutations that sometimes occur in the wild, like a mutation in the MSTN 
gene that already occurs naturally in some beef cattle breeds. The benefits of using genome 
editing in animal breeding are that genetic gain can be reached faster than with only selective 
breeding. The new techniques are thought to revolutionize the biomedical research field as 
well as solving the need for expanding food production for a growing population. 
Incorporating animal within the biomedical field sees endless opportunities. Among some 
examples, cows and goats can be used as bioreactors to produce certain substances in their 
milk and pigs can be used as organ donors. Medicines will also be customized to suit 
individual genome with genome editing techniques (Gaj et al., 2013; Sander & Joung, 2014).  
 
Negative aspects of GE 
Genome editing is not yet approved by governments, which is the first holdback to apply the 
technique widely in animal breeding. The desired traits are often controlled by several 
quantitative trait nucleotides (QTN) and it can be hard to exactly know which gene controls 
which trait, as well as to predict underlying epistatic effects. To be able to edit the genome, 
favorable alleles will need to be identified by associating genotypes with corresponding 
phenotypes. With genomic selection (GS) being more popular within farm animal breeding it 
is thought to create a large dataset with needed information to implement GE in a safe and 
well controlled manor (Jenko et al., 2015).  
 
People that are in opposition to genetically engineered animals argue that it will disturb the 
biological diversity, especially if edited individuals breed with their wild type relatives. That 
is the reason why genetically engineered animals need to be contained in well secured areas. 
That is also partly the reason why genetically engineered animals are so far very expensive to 
keep. Critics called the Enviropig® the frankenswine and refused to accept the facts that it was 
a normal pig with the exception of expressing phytase in the saliva. However, the supporters 
of genetically engineered organisms persist in saying humans have since the first day of 
domestication, may it be a plant or an animal, manipulated the development of the organisms. 
It just takes one look at the beef cattle production to realize that the theory might be right. The 
Belgian Blue, for example, that naturally inherits the knockout of gene function in the MSTN 
gene, expresses double muscling. It has been produced by conventional breeding strategies, 
and it is a proof that the genome has a wide variety to be manipulated only by selective 
breeding. The question remains whether it is ethical to produce such animals.  
 
Conclusion 
Manipulation techniques have so far been used to produce fast growing animals with better 
food utilization traits, disease resistant animals, healthier animal-derived products, 
environmentally friendly animals, pet animals and animals serving a purpose in the 
biomedical research field. Genome editing techniques has not yet been implemented in 
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breeding programs for farm animals. The only reasonable method of incorporating genome 
editing in existing breeding programs would be to introduce few males with edited genome, 
like suggested in the simulation study of Jenko et al., (2015). In the near future it is most 
likely only going to be used within the biomedical field. The negative aspects of using 
genome editing in animal breeding is the low level of success rate in producing live animals. 
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